2Young MD, Gooch WM, Zuckerman A J, et al. Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination [J]. J Med Virol,2001,64 :290 - 298.
5Chan HL, Sung JJ. Hepatocellular carcinoma and hepatitis B vi- rus. Semin Liver Dis, 2006, 26(2) : 153-161.
6Fang ZL, Sabin CA, Dong BQ, et al. Hepatitis B virus pre-S de- letion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study. J Gen Virol, 2008, 89 ( 11 ) : 2882-2890.
7Cimprich KA, Shin TB, Keith CT, et al. cDNA cloning and gene mapping of a candidate human cell cycle checkpoint pro- tein. Proc Natl Acad Sci USA, 1996, 93(7) : 2850-2855.
8Shiloh Y. Ataxia-telangiectasia and the Nijmegen breakage syn- drome: related disorders but genes apart. Annu Rev Genet . 1997, 31 : 635-662.
9Fumari B, Rhind N, Russell P. Cde25 mitotic inducer targeted by chkl DNA damage checkpoint kinase. Science, 1997, 277 (5331) : 1495-1497.
10Matsuoka S, Huang M, Elledge SJ. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science, 1998, 282 (2395) : 1893-1897.
